Literature DB >> 8183235

Pharmacological characterization of metabotropic glutamate receptors in several types of brain cells in primary cultures.

L Prézeau1, J Carrette, B Helpap, K Curry, J P Pin, J Bockaert.   

Abstract

Several cDNAs coding for metabotropic glutamate receptors (mGluR1-7) have now been isolated. mGluR1 and -5 are positively coupled to phospholipase C, whereas mGluR2, -3, -4, -6, and -7 are negatively coupled to adenylyl cyclase (AC) when they are expressed in Chinese hamster ovary or baby hamster kidney cells. However, the exact transduction mechanisms of these receptors in their natural environment remain to be determined. In a previous work, we demonstrated that striatal neurons in primary culture expressed a mGluR that is negatively coupled to AC and that has a pharmacology different from that of mGluR2. In the present study, the pharmacology of mGluRs negatively coupled to AC in several neuronal types and in glial cells was compared with the pharmacology of mGluR2, -3, and -4. Like striatal neurons, cerebral cortical neurons express a mGluR that is able to inhibit AC both in intact cells and in membrane preparations, via a pertussis toxin-sensitive G protein. This mGluR has a pharmacological profile similar to that of mGluR3, because quisqualate is active at relatively low concentrations (EC50 < 100 microM). Similar experiments revealed that cerebellar granule cells expressed mGluR2-like and mGluR4-like receptors. Striatal glial cells also expressed a mGluR negatively coupled to AC via a pertussis toxin-sensitive G protein. However, only glutamate and aspartate, and not quisqualate, 2-(carboxycyclopropyl)glycine, trans-1-aminocyclopentane-1,3-dicarboxylate, or L-2-amino-4-phosphonobutyrate, were agonists for this glial mGluR. This pharmacology is different from that of any cloned mGluR. Reverse transcription associated with polymerase chain reaction revealed that mGluR2 and mGluR3 mRNAs are present in striatal, cortical, and cerebellar neurons but not in striatal glial cells. Interestingly, mGluR4 mRNA was found at a high level in cerebellar granule cells and at a lower level in cortical neurons and glial cells. However, the mGluR4-specific agonist L-2-amino-4-phosphonobutyrate was found to inhibit AC very slightly in granule cells only. In conclusion, our data show that mGluR2- and mGluR3-like receptors can directly inhibit AC in neurons, and they raise the question of whether mGluR4 is really negatively coupled to AC in its normal environment. We also present evidence for a new mGluR subtype expressed in glial cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8183235

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  16 in total

1.  Metabotropic glutamate receptor expression in cultured rat astrocytes and human gliomas.

Authors:  D F Condorelli; P Dell'Albani; M Corsaro; R Giuffrida; A Caruso; A Trovato Salinaro; F Spinella; F Nicoletti; V Albanese; A M Giuffrida Stella
Journal:  Neurochem Res       Date:  1997-09       Impact factor: 3.996

2.  A new signalling pathway for parallel fibre presynaptic type 4 metabotropic glutamate receptors (mGluR4) in the rat cerebellar cortex.

Authors:  Karine Abitbol; Heather McLean; Thomas Bessiron; Hervé Daniel
Journal:  J Physiol       Date:  2012-05-08       Impact factor: 5.182

3.  Impaired cerebellar synaptic plasticity and motor performance in mice lacking the mGluR4 subtype of metabotropic glutamate receptor.

Authors:  R Pekhletski; R Gerlai; L S Overstreet; X P Huang; N Agopyan; N T Slater; W Abramow-Newerly; J C Roder; D R Hampson
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

4.  The acid-sensitive, anesthetic-activated potassium leak channel, KCNK3, is regulated by 14-3-3β-dependent, protein kinase C (PKC)-mediated endocytic trafficking.

Authors:  Luke Gabriel; Anatoli Lvov; Demetra Orthodoxou; Ann R Rittenhouse; William R Kobertz; Haley E Melikian
Journal:  J Biol Chem       Date:  2012-07-30       Impact factor: 5.157

5.  BAY36-7620: a potent non-competitive mGlu1 receptor antagonist with inverse agonist activity.

Authors:  F Y Carroll; A Stolle; P M Beart; A Voerste; I Brabet; F Mauler; C Joly; H Antonicek; J Bockaert; T Müller; J P Pin; L Prézeau
Journal:  Mol Pharmacol       Date:  2001-05       Impact factor: 4.436

6.  Dendritic and axonal targeting of type 5 metabotropic glutamate receptor is regulated by homer1 proteins and neuronal excitation.

Authors:  F Ango; J P Pin; J C Tu; B Xiao; P F Worley; J Bockaert; L Fagni
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

7.  cAMP-dependent protein kinase inhibits mGluR2 coupling to G-proteins by direct receptor phosphorylation.

Authors:  H Schaffhauser; Z Cai; F Hubalek; T A Macek; J Pohl; T J Murphy; P J Conn
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

8.  Selective blockade of P/Q-type calcium channels by the metabotropic glutamate receptor type 7 involves a phospholipase C pathway in neurons.

Authors:  J Perroy; L Prezeau; M De Waard; R Shigemoto; J Bockaert; L Fagni
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

9.  Characterization of metabotropic glutamate receptor-stimulated phosphoinositide hydrolysis in rat cultured cerebellar granule cells.

Authors:  N J Toms; D E Jane; H W Tse; P J Roberts
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

Review 10.  Neurovascular signaling in the brain and the pathological consequences of hypertension.

Authors:  Kathryn M Dunn; Mark T Nelson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-10-25       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.